Alexandra MacLean Email

CEO and Member Board Directors . Avenue Therapeutics

Current Roles

Employees:
12
Revenue:
$1.9M
About
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol for the management of moderate to moderately severe postoperative pain. IV tramadol may fill a gap in the acute pain market between IV acetaminophen/NSAIDS and IV conventional narcotics. Avenue is currently evaluating IV tramadol in a pivotal Phase 3 program for the management of postoperative pain.
Avenue Therapeutics Address
2 Gansevoort Street
New York, NY
United States
Avenue Therapeutics Email